[Experience with the contrast medium Telebrix 300 in neuroradiology (author's transl)].
Clinical experience with a new tri-iodized contrast medium (Telebrix 300) in cerebral angiography is reported. In one of its forms, Telebrix is available as the pure methylglucamine salt of the newly developed ioxitalaminoacid in 66% aqueous solution, with an iodine content of 300 mg/ml. The results of the use of Telebrix 300 in 302 patients examined with over 600 single vascular visualisations (direct puncture and catheter angiography) are communicated. Unforessen incidents with permanent neurological disturbances were not observed. Local and general tolerance of Telebrix 300 is excellent, even after large quantities of the contrast medium (up to 300 ml).
D000293:Adolescent; D000328:Adult; D000368:Aged; D000818:Animals; D002339:Carotid Arteries / Q000000981:diagnostic imaging; D002404:Catheterization; D055598:Chemical Phenomena; D002621:Chemistry; D003287:Contrast Media; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D007483:Iothalamic Acid / Q000009:adverse effects / Q000031:analogs & derivatives*; D007928:Lethal Dose 50; D008297:Male; D008875:Middle Aged; D009485:Neuroradiography / Q000379:methods; D011677:Punctures; D051381:Rats; D014711:Vertebral Artery / Q000000981:diagnostic imaging
D003287:Contrast Media; D007483:Iothalamic Acid
Erfahrungen mit dem Röntgenkontrastmittel Telbrix 300 in der Neuroradiologie